The B-type natriuretic peptide assay: A rapid test for heart failure

Cleveland Clinic Journal of Medicine

Volumn 69, Issue 3, 2002, Pages 243-251

  Peacock IV, W Frank ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FIRST AID; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; OUTPATIENT CARE; PREDICTION; REVIEW; SCREENING TEST;

EID: 0036121481     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.3.243     Document Type: Review

References (51)

1. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
2. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: Conflicting results may lead to inappropriate care
3. Consensus recommendations for the management of chronic heart failure
4. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study
5. Bedside cardiovascular examination in patients with severe chronic heart failure: Importance of rest or inducible jugular venous distention
6. Clinical diagnosis of congestive heart failure in patients with acute dyspnea
7. The bedside chest radiograph in the evaluation of incipient heart failure
8. Detection of pleural effusions on supine chest radiographs
9. The limited availability of physical signs for estimating hemodynamics in chronic heart failure
10. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction
11. Clinical significance of normal cardiac silhouette in dilated cardiomyopathy: Evaluation based upon echocardiography and magnetic resonance imaging
12. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria
13. Open access echocardiography in management of heart failure in the community
14. Validity of clinical diagnosis of heart failure in primary health care
15. Echocardiography in chronic heart failure in the community
16. Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction
17. The natural history of congestive heart failure: The Framingham Study
18. Clinical diagnosis of congestive heart failure in patients with acute dyspnea
19. Ten years of natriuretic peptide research: A new dawn for their diagnostic and therapeutic use?
20. Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide
21. Natriuretic peptide system in human heart failure
22. Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment
23. Natriuretic peptides in assessment of left-ventricular dysfunction
24. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases
25. Relationship between left ventricular geometry and brain natriuretic peptide levels in elderly subjects
26. Aging and left ventricular function in elderly healthy people
27. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension
28. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting
29. Plasma B-type natriuretic peptide measurement in a multiphasic health screening program
30. Plasma brain natriuretic peptide in assessment of acute dyspnea
31. Biochemical detection of left ventricular systolic dysfunction
32. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study
33. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: Influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation
34. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction
35. Plasma brain natriuretic peptide: An independent predictor of cardiovascular mortality in acute heart failure
36. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension
37. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia
38. Evaluation of brain natriuretic peptide in the diagnosis of heart failure
39. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
40. Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy
41. Antihypertensive therapy reduces increased plasma levels of adreno-medullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension
42. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
43. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and peptide
44. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty
45. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction
46. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction
47. The utility of brain natriuretic peptides in patients with heart failure and coronary artery disease
48. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina
49. Guidelines for the diagnosis and treatment of chronic heart failure
50. Profile of plasma N-terminal proBNP following acute myocardial infarction
51. Clinical significance of brain natriuretic peptide in patients with postmyocardial infarction